{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:29Z","timestamp":1791216569718,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharep.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T10:21:55Z","timestamp":1475922115000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression"],"prefix":"10.1007","volume":"69","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1408-4295","authenticated-orcid":false,"given":"Rajesh Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"10","key":"10.1016\/j.pharep.2016.10.001_bib0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.pharep.2016.10.001_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharep.2016.10.001_bib0015","first-page":"809843","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","volume":"2012","author":"Garcia","year":"2012","journal-title":"Epilepsy Res Treat"},{"key":"10.1016\/j.pharep.2016.10.001_bib0020","first-page":"12","article-title":"Antidepressants for people with epilepsy and depression","author":"Maguire","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pharep.2016.10.001_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/phar.1549","article-title":"Breakthrough seizures after starting vilazodone for depression","volume":"35","author":"McKean","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.pharep.2016.10.001_bib0030","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2016.10.001_bib0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1528-1167.2008.01813.x","article-title":"The NINDS epilepsy research benchmarks","volume":"50","author":"Kelley","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2016.10.001_bib0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yebeh.2016.05.005","article-title":"Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression","volume":"61","author":"Singh","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.pharep.2016.10.001_bib0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1471-4159.2000.740792.x","article-title":"Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats","volume":"74","author":"Han","year":"2000","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharep.2016.10.001_bib0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.neuroscience.2008.12.040","article-title":"Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase","volume":"159","author":"Itoh","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2016.10.001_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2013.06.043","article-title":"Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase","volume":"1530","author":"Danjo","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2016.10.001_bib0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainresbull.2016.01.010","article-title":"Neuronal nitric oxide synthase contributes to pentylenetetrazole-kindling-induced hippocampal neurogenesis","volume":"121","author":"Zhu","year":"2016","journal-title":"Brain Res Bull"},{"issue":"7","key":"10.1016\/j.pharep.2016.10.001_bib0065","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2174\/187152711798072347","article-title":"Nitric oxide: epileptic seizures, and action of antiepileptic drugs","volume":"10","author":"Banach","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pharep.2016.10.001_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ph3010273","article-title":"Nitric oxide synthase inhibitors as antidepressants","volume":"3","author":"Wegener","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.pharep.2016.10.001_bib0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"21","key":"10.1016\/j.pharep.2016.10.001_bib0080","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1523\/JNEUROSCI.0004-11.2011","article-title":"Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviours of glucocorticoids by downregulating glucocorticoid receptor","volume":"31","author":"Zhou","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharep.2016.10.001_bib0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FBP.0000000000000035","article-title":"Hippocampal nNOS inhibition induces an antidepressant-like effect: involvement of 5HT1A receptors","volume":"25","author":"Hiroaki-Sato","year":"2014","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharep.2016.10.001_bib0090","doi-asserted-by":"crossref","first-page":"745613","DOI":"10.1155\/2015\/745613","article-title":"Seizure-induced oxidative stress in temporal lobe epilepsy","volume":"2015","author":"Puttachary","year":"2015","journal-title":"Biomed Res Int"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2016.10.001_bib0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-2999(00)00086-8","article-title":"7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA\/2 mice","volume":"394","author":"De Sarro","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2016.10.001_bib0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00702-005-0417-y","article-title":"7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"113","author":"Luszczki","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.pharep.2016.10.001_bib0105","first-page":"697","article-title":"Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-\u03b1 and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats","volume":"9","author":"Mohamed","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"10.1016\/j.pharep.2016.10.001_bib0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1476-5381.1993.tb12798.x","article-title":"7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure","volume":"108","author":"Moore","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2016.10.001_bib0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2016.10.001_bib0120","first-page":"3638","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.pharep.2016.10.001_bib0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbi.2014.06.205","article-title":"Bacillus Calmette-Gu\u00e9rin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice","volume":"42","author":"Kumar","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.pharep.2016.10.001_bib0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.yebeh.2005.08.019","article-title":"Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats","volume":"7","author":"Mortazavi","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pharep.2016.10.001_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-11-41","article-title":"Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy","volume":"11","author":"Xie","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pharep.2016.10.001_bib0140","series-title":"Targeting the broadly pathogenic kynurenine pathway","article-title":"Role of the kynurenine pathway in epilepsy","year":"2015"},{"issue":"4","key":"10.1016\/j.pharep.2016.10.001_bib0145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2016.10.001_bib0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2011.02.013","article-title":"Preclinical activity profile of \u03b1-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy","volume":"95","author":"Citraro","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2016.10.001_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuroscience.2012.12.052","article-title":"The kynurenine pathway: a missing piece in the puzzle of valproate action","volume":"234","author":"Maciejak","year":"2013","journal-title":"Neuroscience"},{"issue":"10 (Pt. 1)","key":"10.1016\/j.pharep.2016.10.001_bib0160","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"10.1016\/j.pharep.2016.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.pharep.2016.10.001_bib0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.WNL.0000149636.44660.99","article-title":"Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy","volume":"64","author":"Van Der Hel","year":"2005","journal-title":"Neurology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:43Z","timestamp":1752611803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.10.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1734114016302419"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.10.001","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}